SocialPicks Sentiment:
** v.s.
other stocks
|
This Quarter's Sentiment:
|
|
|
SocialPicks Community
Bullish on ARNA ...
ARNA
|
|
|
ARNA - Break Out http://www.chartspread.com/stockcharts.php/?ticker=arna Arena Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in discovering, developing, and commercializing oral drugs in the therapeutic areas of cardiovascular, central nervous system, inflammatory, and metabolic diseases.
|
10 Extreme Trades on Pending Clinical Trial Results
ARNA
FDA, Clinical Trial Calendar Updates: Weight Loss, Diabetes, and More
ARNA
|
|
|
<> The FDA Calendar includes companies with pending new drug, biological agent, or medical device new product decisions at the FDA sorted by their PDUFA deadline dates. The entries are updated on a daily basis as new information becomes available with a total of 110 entries through 4/1/09. The FDA Calendar includes the following information: company name, ticker, decision d...
|
A Calendar of Expected Clinical Trial Results
ARNA
|
|
|
<> 
The accompanying table [click to enlarge] includes 58 entries of expected clinical trial results in addition to pending FDA applications for new product approvals + a list of companies which will be required to re-submit their applications due to complete response letters from the agency.
See my recent article on 20 emerging healthcare stocks to watch in 2009 for more details on some of the companies included in the accompanying calendar, in addition to the following companies with near-term catalysts in...
|
BIG STOCK TO GET
ARNA
|
|
|
<> shares gained 7.9% after the company said its first-quarter loss widened, due in part to costs related to the Phase III lorcaserin Bloom trial. The first quarter of 2006 also included a $5 million milestone payment under its collaboration with Ortho-McNeil Pharmaceutical Inc. The San Diego biotechnology company had a first-quarter loss of $31.4 million, or 53 cents a share, compared with a loss of $12.7 million, or 30 cents a share, a year earlier. Arena said revenue for the quarter fell 60% to $4.91 million from $12.1 million a year earlier. This company is going to shoot up big. Look a...
|
|
ROCK-STAR INVESTORS
|
|
POPULAR STOCKS
|
|
TODAY'S HEADLINES
|
|
TODAY'S TOP PICKS
|
|
|
| StreetInsider.com on ARNA |
Visit streetinsider.com
Be the first to start a discussion and earn 2 points.
More Resources
|
About Arena Pharmaceuticals Inc
- Answers.com
